Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchiectasis--new therapeutic approaches based on pathogenesis.

R A Stockley1

  • 1Lung Immunobiochemical Research Laboratory, University of Birmingham, England.

Clinics in Chest Medicine
|September 1, 1987
PubMed
Summary

Antibiotic therapy can improve bronchiectasis symptoms, especially for patients with purulent sputum. Higher antibiotic doses may be needed for treatment resistance, but long-term use carries risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular disease in Alpha 1 antitrypsin deficiency: an observational study assessing the role of neutrophil proteinase activity and the suitability of validated screening tools.

Orphanet journal of rare diseases·2024
Same author

Bronchiectasis: A Progressive Phenotype of Chronic Obstructive Pulmonary Disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Quantitative analysis of protease recognition by inhibitors in plasma using microscale thermophoresis.

Scientific reports·2016
Same author

Cohort Profile: The Birmingham Chronic Obstructive Pulmonary Disease (COPD) Cohort Study.

International journal of epidemiology·2016
Same author

Lung density associates with survival in alpha 1 antitrypsin deficient patients.

Respiratory medicine·2016
Same author

PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.

Thorax·2015

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Microbiology

Background:

  • Bronchiectasis pathogenesis involves complex mechanisms leading to patient deterioration.
  • Current understanding of bacterial colonization and persistence in bronchiectasis is evolving.

Purpose of the Study:

  • To explore new concepts in bronchiectasis pathogenesis.
  • To evaluate the efficacy of modified antibiotic policies for bronchiectasis management.
  • To hypothesize explanations for patient deterioration in bronchiectasis.

Main Methods:

  • Review of recent studies on antibiotic therapy in bronchiectasis.
  • Analysis of treatment responses based on sputum characteristics (purulent vs. non-purulent).
  • Evaluation of short-term and long-term outcomes of antibiotic interventions.

Main Results:

  • Antibiotic therapy is beneficial for patients with purulent sputum, regardless of acute exacerbation status.
  • Broad-spectrum antibiotics are effective for exacerbations caused by H. influenzae and S. pneumoniae.
  • Higher antibiotic dosages may be necessary for treatment failures, particularly with purulent secretions.

Conclusions:

  • Modified antibiotic policies show short- and long-term benefits in bronchiectasis.
  • Long-term antibiotic therapy can improve patient well-being and reduce pathogenic mechanisms.
  • Future research aims to develop targeted therapies to reduce reliance on long-term antibiotics and mitigate resistance risks.

Related Experiment Videos